查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1888572

良性阵发性位置性眩晕市场规模、份额和趋势分析报告：按治疗药物、类型、分销管道、地区和细分市场预测（2025-2033 年）

Benign Positional Vertigo Market Size, Share & Trends Analysis Report By Therapeutics (Vestibular Function Restoratives, Antivertigo H1 Antihistamines), By Type (Branded, Generic), By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

良性阵发性位置性眩晕市场摘要

2024年全球良性阵发性位置性眩晕眩晕市场规模估计为18.4亿美元，预计2033年将达到27.3亿美元。

预计从 2025 年到 2033 年，良性阵发性位置性眩晕产业的发展动力来自前庭疾病盛行率的上升、对平衡相关疾病认识的提高，以及眼震图 (VNG) 和磁振造影(MRI) 等诊断工具的进步。

老年人口不断增长，而老年人更容易出现内耳功能障碍，这也推动了市场成长。前庭復健疗法和药物治疗（包括抗组织胺和前庭抑制剂）的广泛应用也促进了需求。此外，前庭功能障碍机制研究的进展可望提高治疗的可近性和普及率。

前庭功能障碍的增加和人口老化的加剧，使得良性阵发性位置性眩晕）的有效治疗方法在广泛的患者群体中日益受到重视。诊断工具、非侵入性治疗和引导復位装置的进步提高了诊断的准确性、患者的舒适度和临床疗效。前庭功能障碍的老龄化增长而增加，从而形成了一个庞大的高危险群。 2023年7月发表在《国际耳鼻喉头颈外科杂誌》（International Journal of Otorhinolaryngology and Head and Neck Surgery）上的一项研究报告称，40岁及以上人群中与老龄化相关的前庭功能下降的总体患病率为35.4%，这凸显了需要针对性干预的庞大患者群体患病率。

目录

第一章调查方法和范围

第二章执行摘要

第三章良性阵发性位置性眩晕眩晕市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关及辅助市场展望
  • 市场动态
  • 良性阵发性位置性眩晕市场分析工具
    • 产业分析：波特五力模型
    • PESTEL 分析

第四章良性阵发性位置性眩晕市场：治疗药物估算与趋势分析

  • 良性阵发性位置性眩晕眩晕：治疗药物的变异分析
  • 良性阵发性位置性眩晕市场规模及趋势分析（依治疗方法，2021-2033 年）
  • 前庭功能恢復剂
  • 抗眩晕 H1 抗组织胺药
  • 苯二氮平类药物
  • 其他的

第五章良性阵发性位置性眩晕市场：类型估计与趋势分析

  • 良性阵发性位置性眩晕市场：类型差异分析
  • 良性阵发性位置性眩晕市场规模及趋势分析（按类型划分，2021-2033 年）
  • 品牌
  • 非专利的

第六章良性阵发性位置性眩晕市场：通路预测与趋势分析

  • 良性阵发性位置性眩晕市场：通路波动分析
  • 良性阵发性位置性眩晕市场规模及趋势分析（依通路划分，2021-2033 年）
  • 医院药房
  • 网路药房
  • 其他的

第七章良性阵发性位置性眩晕市场：区域估计与趋势分析

  • 区域市场占有率分析（2024 年和 2033 年）
  • 区域市场概览
  • 市场规模及预测趋势分析（2021-2033）：
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争情势

  • 公司/竞争对手分类
  • 策略规划
  • 2024年商业市场分析
  • 公司简介/列表
    • Viatris Inc.
    • Pfizer Inc.
    • Zydus Group
    • Prestige Consumer Healthcare Inc
    • GSK plc
    • Novartis AG
    • Johnson &Johnson
    • Teva Pharmaceutical Industries Ltd.
    • Sun Pharmaceutical Industries Ltd.
Product Code: GVR-4-68040-790-1

Benign Positional Vertigo Market Summary

The global benign positional vertigo market size was estimated at USD 1.84 billion in 2024 and is projected to reach USD 2.73 billion by 2033, growing at a CAGR of 4.5% from 2025 to 2033. The benign positional vertigo industry is driven by the growing prevalence of vestibular disorders, increased awareness of balance-related conditions, and advancements in diagnostic tools such as videonystagmography (VNG) and magnetic resonance imaging (MRI).

Rising geriatric population prone to inner ear dysfunctions further supports market growth. Expanding use of vestibular rehabilitation therapy and pharmacological treatments, including antihistamines and vestibular suppressants, is contributing to demand. In addition, increasing research on vestibular dysfunction mechanisms is expected to enhance treatment accessibility and adoption.

The rise in vestibular disorders and the growing elderly population drive demand for effective treatment options for benign positional vertigo across a wide patient base. Advances in diagnostic tools, non-invasive therapies, and guided repositioning devices have improved accuracy, patient comfort, and clinical outcomes. Vestibular impairments occur frequently with age, creating a substantial population at risk. According to an article published in the International Journal of Otorhinolaryngology and Head and Neck Surgery in July 2023, the overall prevalence of age-related vestibular loss was reported to be 35.4% among individuals aged over 40 years, highlighting the substantial patient pool requiring targeted interventions.

Global Benign Positional Vertigo Market Report Segmentation

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global benign positional vertigo market report based on the therapeutics, type, distribution channel, and region:

  • Therapeutics Outlook (Revenue, USD Million, 2021 - 2033)
  • Vestibular Function Restoratives
  • Antivertigo H1 Antihistamines
  • Benzodiazepines
  • Others
  • Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Branded
  • Generic
  • Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospital Pharmacies
  • Online Pharmacies
  • Other
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • MEA
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1 Market Segmentation & Scope
  • 1.2 Segment Definitions
    • 1.2.1 Therapeutics
    • 1.2.2 Type
    • 1.2.3 Distribution Channel
  • 1.3 Research Methodology
  • 1.4 Information Procurement
    • 1.4.1 Purchased database
    • 1.4.2 GVR's internal database
    • 1.4.3 Secondary sources
    • 1.4.4 Primary research
  • 1.5 Information or Data Analysis
    • 1.5.1 Data analysis models
  • 1.6 Market Formulation & Validation
  • 1.7 Model Details
  • 1.8 List of Secondary Sources
  • 1.9 List of Primary Sources
  • 1.10 Objectives

Chapter 2 Executive Summary

  • 2.1 Market Outlook
  • 2.2 Segment Snapshot
  • 2.3 Competitive Insights Landscape

Chapter 3 Benign Positional Vertigo Market Variables, Trends & Scope

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent market outlook
    • 3.1.2 Related/ancillary market outlook.
  • 3.2 Market Dynamics
    • 3.2.1 Market driver analysis
    • 3.2.2 Market restraint analysis
  • 3.3 Benign Positional Vertigo Market Analysis Tools
    • 3.3.1 Industry Analysis - Porter's
    • 3.3.2 PESTEL Analysis

Chapter 4 Benign Positional Vertigo Market: Therapeutics Estimates & Trend Analysis

  • 4.1 Segment Dashboard
  • 4.2 Benign Positional Vertigo Market Therapeutics Movement Analysis
  • 4.3 Benign Positional Vertigo Market Size & Trend Analysis, by Therapeutics, 2021 to 2033 (USD Million)
  • 4.4 Vestibular Function Restoratives
    • 4.4.1 Vestibular function restoratives market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.5 Antivertigo H1 Antihistamines
    • 4.5.1 Antivertigo H1 antihistamines market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.6 Benzodiazepines
    • 4.6.1 Benzodiazepines market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.7 Others
    • 4.7.1 Others market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 5 Benign Positional Vertigo Market: Type Estimates & Trend Analysis

  • 5.1 Segment Dashboard
  • 5.2 Benign Positional Vertigo Market Type Movement Analysis
  • 5.3 Benign Positional Vertigo Market Size & Trend Analysis, by Type, 2021 to 2033 (USD Million)
  • 5.4 Branded
    • 5.4.1 Branded market estimates and forecasts, 2021 to 2033 (USD Million)
  • 5.5 Generic
    • 5.5.1 Generic market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 6 Benign Positional Vertigo Market: Distribution Channel Estimates & Trend Analysis

  • 6.1 Segment Dashboard
  • 6.2 Benign Positional Vertigo Market Distribution Channel Movement Analysis
  • 6.3 Benign Positional Vertigo Market Size & Trend Analysis, by Distribution Channel, 2021 to 2033 (USD Million)
  • 6.4 Hospital Pharmacies
    • 6.4.1 Hospital pharmacies market estimates and forecasts, 2021 to 2033 (USD Million)
  • 6.5 Online Pharmacies
    • 6.5.1 Online pharmacies market estimates and forecasts, 2021 to 2033 (USD Million)
  • 6.6 Others
    • 6.6.1 Others market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 7 Benign Positional Vertigo Market: Regional Estimates & Trend Analysis

  • 7.1 Regional Market Share Analysis, 2024 & 2033
  • 7.2 Regional Market Dashboard
  • 7.3 Market Size, & Forecasts Trend Analysis, 2021 to 2033:
  • 7.4 North America
    • 7.4.1 U.S.
      • 7.4.1.1 Key country dynamics
      • 7.4.1.2 U.S. market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.4.2 Canada
      • 7.4.2.1 Key country dynamics
      • 7.4.2.2 Canada market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.4.3 Mexico
      • 7.4.3.1 Key country dynamics
      • 7.4.3.2 Mexico market estimates and forecasts, 2021 to 2033 (USD Million)
  • 7.5 Europe
    • 7.5.1 UK
      • 7.5.1.1 Key country dynamics
      • 7.5.1.2 UK market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.5.2 Germany
      • 7.5.2.1 Key country dynamics
      • 7.5.2.2 Germany market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.5.3 France
      • 7.5.3.1 Key country dynamics
      • 7.5.3.2 France market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.5.4 Italy
      • 7.5.4.1 Key country dynamics
      • 7.5.4.2 Italy market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.5.5 Spain
      • 7.5.5.1 Key country dynamics
      • 7.5.5.2 Spain market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.5.6 Norway
      • 7.5.6.1 Key country dynamics
      • 7.5.6.2 Norway market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.5.7 Sweden
      • 7.5.7.1 Key country dynamics
      • 7.5.7.2 Sweden market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.5.8 Denmark
      • 7.5.8.1 Key country dynamics
      • 7.5.8.2 Denmark market estimates and forecasts, 2021 to 2033 (USD Million)
  • 7.6 Asia Pacific
    • 7.6.1 Japan
      • 7.6.1.1 Key country dynamics
      • 7.6.1.2 Japan market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.6.2 China
      • 7.6.2.1 Key country dynamics
      • 7.6.2.2 China market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.6.3 India
      • 7.6.3.1 Key country dynamics
      • 7.6.3.2 India market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.6.4 Australia
      • 7.6.4.1 Key country dynamics
      • 7.6.4.2 Australia market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.6.5 South Korea
      • 7.6.5.1 Key country dynamics
      • 7.6.5.2 South Korea market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.6.6 Thailand
      • 7.6.6.1 Key country dynamics
      • 7.6.6.2 Thailand market estimates and forecasts, 2021 to 2033 (USD Million)
  • 7.7 Latin America
    • 7.7.1 Brazil
      • 7.7.1.1 Key country dynamics
      • 7.7.1.2 Brazil market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.7.2 Argentina
      • 7.7.2.1 Key country dynamics
      • 7.7.2.2 Argentina market estimates and forecasts, 2021 to 2033 (USD Million)
  • 7.8 MEA
    • 7.8.1 South Africa
      • 7.8.1.1 Key country dynamics
      • 7.8.1.2 South Africa market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.8.2 Saudi Arabia
      • 7.8.2.1 Key country dynamics
      • 7.8.2.2 Saudi Arabia market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.8.3 UAE
      • 7.8.3.1 Key country dynamics
      • 7.8.3.2 UAE market estimates and forecasts, 2021 to 2033 (USD Million)
    • 7.8.4 Kuwait
      • 7.8.4.1 Key country dynamics
      • 7.8.4.2 Kuwait market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 8 Competitive Landscape

  • 8.1 Company/Competition Categorization
  • 8.2 Strategy Mapping
  • 8.3 Company Market Position Analysis, 2024
  • 8.4 Company Profiles/Listing
    • 8.4.1 Viatris Inc.
      • 8.4.1.1 Company overview
      • 8.4.1.2 Financial performance
      • 8.4.1.3 Product benchmarking
      • 8.4.1.4 Strategic initiatives
    • 8.4.2 Pfizer Inc.
      • 8.4.2.1 Company overview
      • 8.4.2.2 Financial performance
      • 8.4.2.3 Product benchmarking
      • 8.4.2.4 Strategic initiatives
    • 8.4.3 Zydus Group
      • 8.4.3.1 Company overview
      • 8.4.3.2 Financial performance
      • 8.4.3.3 Product benchmarking
      • 8.4.3.4 Strategic initiatives
    • 8.4.4 Prestige Consumer Healthcare Inc
      • 8.4.4.1 Company overview
      • 8.4.4.2 Financial performance
      • 8.4.4.3 Product benchmarking
      • 8.4.4.4 Strategic initiatives
    • 8.4.5 GSK plc
      • 8.4.5.1 Company overview
      • 8.4.5.2 Financial performance
      • 8.4.5.3 Product benchmarking
      • 8.4.5.4 Strategic initiatives
    • 8.4.6 Novartis AG
      • 8.4.6.1 Company overview
      • 8.4.6.2 Financial performance
      • 8.4.6.3 Product benchmarking
      • 8.4.6.4 Strategic initiatives
    • 8.4.7 Johnson & Johnson
      • 8.4.7.1 Company overview
      • 8.4.7.2 Financial performance
      • 8.4.7.3 Product benchmarking
      • 8.4.7.4 Strategic initiatives
    • 8.4.8 Teva Pharmaceutical Industries Ltd.
      • 8.4.8.1 Company overview
      • 8.4.8.2 Financial performance
      • 8.4.8.3 Product benchmarking
      • 8.4.8.4 Strategic initiatives
    • 8.4.9 Sun Pharmaceutical Industries Ltd.
      • 8.4.9.1 Company overview
      • 8.4.9.2 Financial performance
      • 8.4.9.3 Product benchmarking
      • 8.4.9.4 Strategic initiatives

List of Tables

  • Table 1. List of Abbreviation
  • Table 2. Global Benign Positional Vertigo Market, By Region, 2021 - 2033 (USD Million)
  • Table 3. Global Benign Positional Vertigo Market, By Therapeutics, 2021 - 2033 (USD Million)
  • Table 4. Global Benign Positional Vertigo Market, By Type, 2021 - 2033 (USD Million)
  • Table 5. Global Benign Positional Vertigo Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 6. North America Benign Positional Vertigo Market, By Country, 2021 - 2033 (USD Million)
  • Table 7. North America Benign Positional Vertigo Market, By Therapeutics, 2021 - 2033 (USD Million)
  • Table 8. North America Benign Positional Vertigo Market, By Type, 2021 - 2033 (USD Million)
  • Table 9. North America Benign Positional Vertigo Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 10. U.S. Benign Positional Vertigo Market, By Therapeutics, 2021 - 2033 (USD Million)
  • Table 11. U.S. Benign Positional Vertigo Market, By Type, 2021 - 2033 (USD Million)
  • Table 12. U.S. Benign Positional Vertigo Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 13. Canada Benign Positional Vertigo Market, By Therapeutics, 2021 - 2033 (USD Million)
  • Table 14. Canada Benign Positional Vertigo Market, By Type, 2021 - 2033 (USD Million)
  • Table 15. Canada Benign Positional Vertigo Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 16. Mexico Benign Positional Vertigo Market, By Therapeutics, 2021 - 2033 (USD Million)
  • Table 17. Mexico Benign Positional Vertigo Market, By Type, 2021 - 2033 (USD Million)
  • Table 18. Mexico Benign Positional Vertigo Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 19. Europe Benign Positional Vertigo Market, By Country, 2021 - 2033 (USD Million)
  • Table 20. Europe Benign Positional Vertigo Market, By Therapeutics, 2021 - 2033 (USD Million)
  • Table 21. Europe Benign Positional Vertigo Market, By Type, 2021 - 2033 (USD Million)
  • Table 22. Europe Benign Positional Vertigo Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 23. Germany Benign Positional Vertigo Market, By Therapeutics, 2021 - 2033 (USD Million)
  • Table 24. Germany Benign Positional Vertigo Market, By Type, 2021 - 2033 (USD Million)
  • Table 25. Germany Benign Positional Vertigo Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 26. UK Benign Positional Vertigo Market, By Therapeutics, 2021 - 2033 (USD Million)
  • Table 27. UK Benign Positional Vertigo Market, By Type, 2021 - 2033 (USD Million)
  • Table 28. UK Benign Positional Vertigo Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 29. France Benign Positional Vertigo Market, By Therapeutics, 2021 - 2033 (USD Million)
  • Table 30. France Benign Positional Vertigo Market, By Type, 2021 - 2033 (USD Million)
  • Table 31. France Benign Positional Vertigo Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 32. Italy Benign Positional Vertigo Market, By Therapeutics, 2021 - 2033 (USD Million)
  • Table 33. Italy Benign Positional Vertigo Market, By Type, 2021 - 2033 (USD Million)
  • Table 34. Italy Benign Positional Vertigo Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 35. Spain Benign Positional Vertigo Market, By Therapeutics, 2021 - 2033 (USD Million)
  • Table 36. Spain Benign Positional Vertigo Market, By Type, 2021 - 2033 (USD Million)
  • Table 37. Spain Benign Positional Vertigo Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 38. Denmark Benign Positional Vertigo Market, By Therapeutics, 2021 - 2033 (USD Million)
  • Table 39. Denmark Benign Positional Vertigo Market, By Type, 2021 - 2033 (USD Million)
  • Table 40. Denmark Benign Positional Vertigo Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 41. Sweden Benign Positional Vertigo Market, By Therapeutics, 2021 - 2033 (USD Million)
  • Table 42. Sweden Benign Positional Vertigo Market, By Type, 2021 - 2033 (USD Million)
  • Table 43. Sweden Benign Positional Vertigo Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 44. Norway Benign Positional Vertigo Market, By Therapeutics, 2021 - 2033 (USD Million)
  • Table 45. Norway Benign Positional Vertigo Market, By Type, 2021 - 2033 (USD Million)
  • Table 46. Norway Benign Positional Vertigo Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 47. Asia Pacific Benign Positional Vertigo Market, By Country, 2021 - 2033 (USD Million)
  • Table 48. Asia Pacific Benign Positional Vertigo Market, By Therapeutics, 2021 - 2033 (USD Million)
  • Table 49. Asia Pacific Benign Positional Vertigo Market, By Type, 2021 - 2033 (USD Million)
  • Table 50. Asia Pacific Benign Positional Vertigo Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 51. China Benign Positional Vertigo Market, By Therapeutics, 2021 - 2033 (USD Million)
  • Table 52. China Benign Positional Vertigo Market, By Type, 2021 - 2033 (USD Million)
  • Table 53. China Benign Positional Vertigo Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 54. Japan Benign Positional Vertigo Market, By Therapeutics, 2021 - 2033 (USD Million)
  • Table 55. Japan Benign Positional Vertigo Market, By Type, 2021 - 2033 (USD Million)
  • Table 56. Japan Benign Positional Vertigo Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 57. India Benign Positional Vertigo Market, By Therapeutics, 2021 - 2033 (USD Million)
  • Table 58. India Benign Positional Vertigo Market, By Type, 2021 - 2033 (USD Million)
  • Table 59. India Benign Positional Vertigo Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 60. South Korea Benign Positional Vertigo Market, By Therapeutics, 2021 - 2033 (USD Million)
  • Table 61. South Korea Benign Positional Vertigo Market, By Type, 2021 - 2033 (USD Million)
  • Table 62. South Korea Benign Positional Vertigo Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 63. Australia Benign Positional Vertigo Market, By Therapeutics, 2021 - 2033 (USD Million)
  • Table 64. Australia Benign Positional Vertigo Market, By Type, 2021 - 2033 (USD Million)
  • Table 65. Australia Benign Positional Vertigo Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 66. Thailand Benign Positional Vertigo Market, By Therapeutics, 2021 - 2033 (USD Million)
  • Table 67. Thailand Benign Positional Vertigo Market, By Type, 2021 - 2033 (USD Million)
  • Table 68. Thailand Benign Positional Vertigo Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 69. Latin America Benign Positional Vertigo Market, By Country, 2021 - 2033 (USD Million)
  • Table 70. Latin America Benign Positional Vertigo Market, By Therapeutics, 2021 - 2033 (USD Million)
  • Table 71. Latin America Benign Positional Vertigo Market, By Type, 2021 - 2033 (USD Million)
  • Table 72. Latin America Benign Positional Vertigo Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 73. Brazil Benign Positional Vertigo Market, By Therapeutics, 2021 - 2033 (USD Million)
  • Table 74. Brazil Benign Positional Vertigo Market, By Length, 2021 - 2033 (USD Million)
  • Table 75. Brazil Benign Positional Vertigo Market, By Type, 2021 - 2033 (USD Million)
  • Table 76. Brazil Benign Positional Vertigo Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 77. Argentina Benign Positional Vertigo Market, By Therapeutics, 2021 - 2033 (USD Million)
  • Table 78. Argentina Benign Positional Vertigo Market, By Type, 2021 - 2033 (USD Million)
  • Table 79. Argentina Benign Positional Vertigo Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 80. MEA Benign Positional Vertigo Market, By Country, 2021 - 2033 (USD Million)
  • Table 81. MEA Benign Positional Vertigo Market, By Therapeutics, 2021 - 2033 (USD Million)
  • Table 82. MEA Benign Positional Vertigo Market, By Type, 2021 - 2033 (USD Million)
  • Table 83. MEA Benign Positional Vertigo Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 84. South Africa Benign Positional Vertigo Market, By Therapeutics, 2021 - 2033 (USD Million)
  • Table 85. South Africa Benign Positional Vertigo Market, By Type, 2021 - 2033 (USD Million)
  • Table 86. South Africa Benign Positional Vertigo Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 87. Saudi Arabia Benign Positional Vertigo Market, By Therapeutics, 2021 - 2033 (USD Million)
  • Table 88. Saudi Arabia Benign Positional Vertigo Market, By Type, 2021 - 2033 (USD Million)
  • Table 89. Saudi Arabia Benign Positional Vertigo Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 90. UAE Benign Positional Vertigo Market, By Therapeutics, 2021 - 2033 (USD Million)
  • Table 91. UAE Benign Positional Vertigo Market, By Type, 2021 - 2033 (USD Million)
  • Table 92. UAE Benign Positional Vertigo Market, By Distribution Channel, 2021 - 2033 (USD Million)
  • Table 93. Kuwait Benign Positional Vertigo Market, By Therapeutics, 2021 - 2033 (USD Million)
  • Table 94. Kuwait Benign Positional Vertigo Market, By Type, 2021 - 2033 (USD Million)
  • Table 95. Kuwait Benign Positional Vertigo Market, By Distribution Channel, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Benign positional vertigo market segmentation
  • Fig. 2 Data analysis models
  • Fig. 3 Market formulation and validation
  • Fig. 4 Data validating & publishing
  • Fig. 5 Market research process
  • Fig. 6 Information procurement
  • Fig. 7 Primary research
  • Fig. 8 Value-chain-based sizing & forecasting
  • Fig. 9 QFD modelling for market share assessment
  • Fig. 10 Market formulation & validation
  • Fig. 11 Commodity flow analysis
  • Fig. 12 Market outlook
  • Fig. 13 Segments snapshot
  • Fig. 14 Competitive landscape snapshot
  • Fig. 15 Benign positional vertigo market value, 2024 (USD billion)
  • Fig. 16 Market trends & outlook
  • Fig. 17 PESTEL analysis
  • Fig. 18 Porter's five forces analysis
  • Fig. 19 Benign positional vertigo market: Therapeutics outlook & key takeaways
  • Fig. 20 Benign positional vertigo: Therapeutic movement analysis
  • Fig. 21 Vestibular function restoratives market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 22 Antivertigo H1 antihistamines market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 23 Benzodiazepines market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 24 Others market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 25 Benign positional vertigo: Type outlook & key takeaways
  • Fig. 26 Benign positional vertigo: Type movement analysis
  • Fig. 27 Branded market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 28 Generic market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 29 Benign positional vertigo: Distribution channel outlook & key takeaways
  • Fig. 30 Benign positional vertigo: Distribution channel movement analysis
  • Fig. 31 Hospital pharmacies market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 32 Online pharmacies market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 33 Others market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 34 Regional marketplace outlook, 2023 & 2033 (USD Million)
  • Fig. 35 Regional marketplace: Key takeaways
  • Fig. 36 North America benign positional vertigo market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 37 Key country dynamics
  • Fig. 38 US benign positional vertigo market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 39 Key country dynamics
  • Fig. 40 Canada benign positional vertigo market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 41 Key country dynamics
  • Fig. 42 Mexico benign positional vertigo market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 43 Key country dynamics
  • Fig. 44 Europe benign positional vertigo market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 45 Key country dynamics
  • Fig. 46 UK benign positional vertigo market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 47 Key country dynamics
  • Fig. 48 Germany benign positional vertigo market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 49 Key country dynamics
  • Fig. 50 France benign positional vertigo market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 51 Key country dynamics
  • Fig. 52 Spain benign positional vertigo market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 53 Key country dynamics
  • Fig. 54 Italy benign positional vertigo market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 55 Key country dynamics
  • Fig. 56 Denmark benign positional vertigo market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 57 Key country dynamics
  • Fig. 58 Sweden benign positional vertigo market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 59 Key country dynamics
  • Fig. 60 Norway benign positional vertigo market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 61 Key country dynamics
  • Fig. 62 Asia Pacific benign positional vertigo market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 63 Key country dynamics
  • Fig. 64 Japan benign positional vertigo market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 65 Key country dynamics
  • Fig. 66 China benign positional vertigo market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 67 Key country dynamics
  • Fig. 68 India benign positional vertigo market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 69 Key country dynamics
  • Fig. 70 Australia benign positional vertigo market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 71 Key country dynamics
  • Fig. 72 Thailand benign positional vertigo market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 73 Key country dynamics
  • Fig. 74 South Korea benign positional vertigo market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 75 Latin America benign positional vertigo market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 76 Key country dynamics
  • Fig. 77 Brazil benign positional vertigo market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 78 Key country dynamics
  • Fig. 79 Argentina benign positional vertigo market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 80 Key country dynamics
  • Fig. 81 MEA benign positional vertigo market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 82 Key country dynamics
  • Fig. 83 South Africa benign positional vertigo market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 84 Key country dynamics
  • Fig. 85 Saudi Arabia benign positional vertigo market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 86 Key country dynamics
  • Fig. 87 UAE benign positional vertigo market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 88 Key country dynamics
  • Fig. 89 Kuwait benign positional vertigo market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 90 Market participant categorization
  • Fig. 91 Global benign positional vertigo market position analysis, 2023
  • Fig. 92 Strategic framework